Acquired Deficit of Antithrombin and Role of Supplementation in Septic Patients During Continuous Veno-Venous Hemofiltration

Authors:

Abstract
Continuous renal replacement therapy (CRRT) is widely used in the management of septic patients with acute renal failure (ARF). Short filter lifespan (p < 0.05). Continuous infusion provided better results: 48.5 vs. 27.8 hours for bolus method. This study suggests that AT measurement should be considered in continuous veno-venous hemofiltration with clotting problems as supplementation could increase filter lifespan by more than 100%. Continuous infusion is preferable. Cost effectiveness should be evaluated shortly.

This publication has 33 references indexed in Scilit: